Medical Device Clinical Trials and Regulations in China

Medical Device Clinical Trials and Regulations in China

China is a major player in the medical device industry, and with its diverse population and expanding healthcare market, companies need to understand the necessary clinical trial requirements for medical device products in this region. The Chinese government has implemented a variety of regulations to ensure the safety and efficacy of medical devices being placed on the market.

Regulatory Frameworks

The National Medical Products Administration (NMPA) is responsible for approving the clinical trials conducted in China. To regulate the clinical trial process in China, the NMPA has released certain guidelines.

Initially, China implemented the Medical Device Clinical Trial Regulation (MDCTR) to set out the requirements for conducting clinical trials of medical devices. Conducting clinical trials of medical devices within the territory of the People's Republic of China (PRC) shall comply with this regulation. The whole process of clinical trials of medical devices includes the design, implementation, supervision, verification, and inspection of clinical trials, as well as the collection, recording, analysis, summary, and report of data.  

In addition to the MDCTR, China has also implemented the Good Clinical Practice (GCP) regulation. This regulation sets standards for conducting clinical trials of medical devices in China. It requires that clinical trials be conducted in accordance with international standards and that the data collected is accurate and reliable. The GCP also requires that the clinical trial be conducted in a fair and ethical manner and that the data be collected in a timely manner.

Finally, China has implemented the Medical Device Registration Regulation (MDRR). This regulation sets out the requirements for registering medical devices in China. The MDRR requires medical device manufacturers to submit an application to the NMPA for device registration. The application must include a detailed device description and safety and efficacy data from clinical trials.

Let’s take a closer look at each phase to better understand what goes into early clinical trials and preparation for the approval of a medical device.

Pre-Preparation for Clinical Trial

Before the clinical trial, the company should complete the preclinical study of the medical device for the trial, including product design (structure composition, working principle, mechanism of action, intended use and scope of application, applicable technical requirements), quality inspection, animal testing, and risk analysis, and the results should be able to support the clinical trial. The quality inspection results include the self-inspection report and the product registration inspection report issued by a qualified testing center within one year.

Approval Process

In order to conduct a clinical trial in China, the clinical trial must be approved by the ethics committee of the medical device clinical trial institution. If the product is listed under Class III medical devices requiring clinical trial approval, it must also be approved by the NMPA. The approval process typically takes six (06) to twelve (12) months, depending on the complexity of the clinical trial. Companies must also provide documentation such as the clinical trial protocol, the investigator's handbook, the text of the informed consent form, any other written materials provided to the subjects, procedural documents for recruiting and publicizing subjects, a self-inspection report, and a product registration testing report, and so on.

Medical device clinical trials are an important part of the product development process, and it is important for companies to understand the requirements for conducting clinical trials in China. Companies must ensure that they meet the necessary Regulatory requirements, including the approval process and associated fees, to ensure the safety and efficacy of their products. Foreign manufacturers wishing to place their products in the Chinese market may opt to collaborate with a professional Regulatory expert for smooth entry into the market.

To Decode more about Clinical Trials Regulations in China, Consult a Regulatory expert now!


No.99-OL-10-202105025, West section,
Hupan Road, Xinglong Street,
Tianfu New District, China (Sichuan)
Pilot Free Trade Zone, China

Have a Business Query? Let us Talk.